Otofarma SpAMIL:OTO -1.43%16 Receivables Turnover is 4.36 as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review. Among 812 Medical Devices & Instruments companies, Otofarma SpA ranks worse than 69.21% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Otofarma SpA's Revenue for the
six
months ended in Dec. 2024 was €15.20 Mil. Otofarma SpA's average Accounts Receivable for the
six
months ended in Dec. 2024 was €3.48 Mil.
Hence, Otofarma SpA's Receivables Turnover for the
six
months ended in Dec. 2024 was 4.36.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Otofarma SpA Receivables Turnover Related Terms
Otofarma SpA Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Otofarma SpA's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otofarma SpA Receivables Turnover Chart
Otofarma SpA Annual Data
Trend
Dec23
Dec24
Receivables Turnover
3.51
4.36
Otofarma SpA Semi-Annual Data
Dec23
Dec24
Receivables Turnover
3.51
4.36
MIL:OTO vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, Otofarma SpA's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Otofarma SpA Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Otofarma SpA's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Otofarma SpA's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otofarma SpA (MIL:OTO) has a Receivables Turnover of 4.36 as of Dec. 2024. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Otofarma SpA and its competitors. According to the industry distribution chart, Otofarma SpA ranks #562 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 69.2%.
Is Otofarma SpA's Receivables Turnover too high?
Otofarma SpA's current Receivables Turnover is 4.36. The Medical Devices & Instruments industry median Receivables Turnover is 5.53. Otofarma SpA's value of 4.36 is 21.2% below this industry median. Based on the distribution chart, Otofarma SpA ranks #562 out of 812 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Otofarma SpA ranks #562 out of 812 companies for Receivables Turnover. This places Otofarma SpA in the lower half of its industry. The industry median Receivables Turnover is 5.53. Otofarma SpA's value of 4.36 is 21.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.53, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Otofarma SpA's current Receivables Turnover of 4.36 is 21.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Otofarma SpA and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Otofarma SpA's current Receivables Turnover is 4.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Receivables Turnover of 4.36. The current Receivables Turnover is 4.36 and 21.2% below the Medical Devices & Instruments industry median of 5.53. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Receivables Turnover is 4.36 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score
Get the complete analysis for MIL:OTO
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:OTO has been successfully added to your 